Treatment Advances For Slow-Growing Non-Hodgkin Lymphomas
March 29, 2019
Topics Covered
We invite you to learn more about:
- The importance of knowing your non-Hodgkin lymphoma (NHL) subtype
- Current and emerging therapies
- Managing side-effects of treatment
- The benefit of discussing quality-of-life concerns with your healthcare team
Speakers
Jonathon B. Cohen, MD, MS
Assistant Professor, Hematology and Medical Oncology
Director, Lymphoma Clinical Trials Working Group
Winship Cancer Institute of Emory University
Atlanta, GA
Audio Replay
Program Materials
Program Support
Support for this program is provided by Bristol-Myers Squibb; Genentech and Biogen; Pharmacyclics, an AbbVie company and Janssen Biotech.